Inflammatory Mechanisms in Pulmonary Tuberculosis

Pulmonary tuberculosis arises when Mycobacterium tuberculosis is inhaled into the alveoli and engages innate immune receptors on macrophages and dendritic cells. Phagocytosed bacilli trigger a cascade of cytokines, including tumour necrosis factor-alpha and interferon-gamma, which orchestrate granuloma formation to contain the infection. An intricate balance between pro-inflammatory mediators and anti-inflammatory signals such as interleukin-10 determines granuloma stability and bacterial containment. Dysregulated activation of matrix metalloproteinases by recruited leukocytes and stromal cells degrades extracellular matrix, leading to caseous necrosis and cavitation. Platelets and complement components further amplify local inflammation, while autoantibody production and B-cell subset alterations suggest an autoimmune component to persistent disease. Angiogenic pathways driven by vascular endothelial growth factor reshape the microvasculature and can facilitate systemic dissemination of bacilli. Understanding these interconnected inflammatory networks has underpinned the development of host-directed therapies, novel biomarkers and improved diagnostic algorithms to reduce global tuberculosis morbidity and mortality.

Research from Nature Portfolio

Recent studies have revealed that M. tuberculosis–infected macrophages secrete vascular endothelial growth factor, promoting angiogenesis within pulmonary granulomas and thereby aiding bacterial egress and dissemination. Inhibition of this pathway in animal models reduces spread from the primary lesion and supports the view of angiogenic blockade as a potential adjunctive therapy. In parallel, work on inflammatory dendritic cells has demonstrated that infected dendritic cells with altered chemokine receptor expression cluster with T cells outside established granulomas, driving the formation of new lesions and sustaining chronic inflammation. These findings underscore the dynamic nature of granuloma architecture and highlight cellular targets for interrupting granulomatous dissemination.

Inflammatory Mechanisms in Pulmonary Tuberculosis publication trend

The graph below shows the total number of articles in inflammatory mechanisms in pulmonary tuberculosis across all publications each year (not limited to Nature Index journals).

Technical terms

Granuloma: A structured aggregate of immune cells formed to contain persistent pathogens within tissue.

Cytokine: A small secreted protein that regulates immune cell communication and inflammatory responses.

Matrix metalloproteinases (MMPs): Enzymes produced by leukocytes that degrade extracellular matrix, contributing to tissue remodelling and damage.

Angiogenesis: The process of new blood vessel formation, which pathogens may exploit to enhance dissemination.

Dendritic cell: Antigen-presenting cell that initiates T-cell responses and influences granuloma dynamics.

References

1. Identification of autoimmune markers in pulmonary tuberculosis. Frontiers in Immunology (2023).
2. Integrating systemic immune-inflammation index, fibrinogen, and T-SPOT.TB for precision distinction of active pulmonary tuberculosis in the era of mycobacterial disease research. Frontiers in Microbiology (2024).
3. Mycobacterium tuberculosis exploits the formation of new blood vessels for its dissemination. Scientific Reports (2016).
4. Platelet Activation and the Immune Response to Tuberculosis. Frontiers in Immunology (2021).
5. Role of TNF‐Alpha, IFN‐Gamma, and IL‐10 in the Development of Pulmonary Tuberculosis. Pulmonary Medicine (2012).
6. Mycobacterium-Infected Dendritic Cells Disseminate Granulomatous Inflammation. Scientific Reports (2015).